Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Glucotrack (GCTK) EPS (Weighted Average and Diluted) (2016 - 2020)

Glucotrack's EPS (Weighted Average and Diluted) history spans 7 years, with the latest figure at $0.31 for Q4 2020.

  • For the quarter ending Q4 2020, EPS (Weighted Average and Diluted) rose 3200.0% year-over-year to $0.31, compared with a TTM value of $0.23 through Dec 2020, up 106.04%, and an annual FY2025 reading of $31.22, down 99.24% over the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2020 was $0.31 at Glucotrack, up from -$0.03 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.31 in Q4 2020, with the low at -$3.78 in Q4 2018.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.43, with a median of -$0.3 recorded in 2016.
  • Year-over-year, EPS (Weighted Average and Diluted) tumbled 704.26% in 2018 and then surged 3200.0% in 2020.
  • Tracing GCTK's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.24 in 2016, then plummeted by 95.83% to -$0.47 in 2017, then tumbled by 704.26% to -$3.78 in 2018, then surged by 99.74% to -$0.01 in 2019, then surged by 3200.0% to $0.31 in 2020.
  • Per Business Quant, the three most recent readings for GCTK's EPS (Weighted Average and Diluted) are $0.31 (Q4 2020), -$0.03 (Q3 2020), and -$0.04 (Q2 2020).